HTT and Huntington disease: Overall, the significant decrease in the mutant Htt protein aggregates number, that is, accumulation as well as the reduction of aggregated and soluble mutant Htt expression, highlight the potential therapeutic role of luteolin in mitigating the pathological effects associated with HD.